dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Serra Peinado, Carla |
dc.contributor.author | Grau Exposito, Judit |
dc.contributor.author | Luque Ballesteros, Laura |
dc.contributor.author | Navarro Mercadé, Jordi |
dc.contributor.author | Gallego Rodriguez, Jenny Carolina |
dc.contributor.author | Martin Castillo, Mario |
dc.contributor.author | Curran Fàbregas, Adria |
dc.contributor.author | Burgos Cibrian, Joaquin |
dc.contributor.author | Ribera Pascuet, Esteve |
dc.contributor.author | Raventos Roca, Berta |
dc.contributor.author | Willekens Morales, Rein Nicolas |
dc.contributor.author | Torrella Domingo, Ariadna |
dc.contributor.author | Planas Ribas, Bibiana |
dc.contributor.author | Badía Royes, Rosa María |
dc.contributor.author | Castellví Vives, Josep |
dc.contributor.author | Genesca Ferrer, Meritxell |
dc.contributor.author | Falcó Ferrer, Vicenç |
dc.contributor.author | Buzón Gómez, María José |
dc.contributor.author | Astorga Gamaza, Antonio |
dc.date.accessioned | 2020-03-02T13:08:47Z |
dc.date.available | 2020-03-02T13:08:47Z |
dc.date.issued | 2019-08-16 |
dc.identifier.citation | Serra-Peinado C, Grau-Expósito J, Luque-Ballesteros L, Astorga-Gamaza A, Navarro J, Gallego-Rodriguez J, et al. Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab. Nat Commun. 2019 Aug 16;10:3705. |
dc.identifier.issn | 2041-1723 |
dc.identifier.uri | https://hdl.handle.net/11351/4691 |
dc.description | Rituximab; Reactivació viral; CD20 |
dc.description.sponsorship | This study was supported by the American National Institutes of Health (grant R21AI118411 to M.B.), the Spanish Secretariat of Science and Innovation and FEDER funds (grant SAF2015-67334-R [MINECO/FEDER]), the Spanish "Ministerio de Economia y Competitividad, Instituto de Salud Carlos III" (ISCIII, PI17/01470), GeSIDA and the Spanish AIDS network Red Tematica Cooperativa de Investigacion en SIDA (RD16/0025/0007). M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179). M.G. is supported by the "Pla estrategic de recerca i innovacio en salut" (PERIS), from the Catalan Government. |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation.ispartofseries | Nature Communications;10 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Rituximab |
dc.subject | Infeccions per VIH |
dc.subject | Cèl·lules T |
dc.subject.mesh | Rituximab |
dc.subject.mesh | HIV Infections |
dc.subject.mesh | CD4-Positive T-Lymphocytes |
dc.title | Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41467-019-11556-4 |
dc.subject.decs | rituximab |
dc.subject.decs | infecciones por VIH |
dc.subject.decs | linfocitos T CD4-positivos |
dc.relation.publishversion | https://www.nature.com/articles/s41467-019-11556-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Serra-Peinado C, Grau-Expósito J, Luque-Ballesteros L, Astorga-Gamaza A, Navarro J, Gallego-Rodriguez J, Martin M, Curran A, Burgos J, Ribera E, Raventós B, Willekens R, Torrella A, Planas B, Badía R, Genescà M, Falcó V, Buzon MJ] Servei de Malalties Infeccioses, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR). Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Castellví J] Servei de Patologia, Hospital Universitari Vall d’Hebron. Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain |
dc.identifier.pmid | 31420544 |
dc.identifier.wos | 000481604300011 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |